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Abstract: Self-assembled peptide hydrogels have brought innovation to the medicinal field, not only 
as responsive biomaterials but also as nanostructured therapeutic agents or as smart drug delivery sys-
tems. D-amino acids are typically introduced to increase the peptide enzymatic stability. However, 
there are several reports of unexpected effects on peptide conformation, self-assembly behavior, cyto-
toxicity and even therapeutic activity. This mini-review discusses all the surprising twists of hetero-
chiral self-assembled peptide hydrogels, and delineates emerging key findings to exploit all the bene-
fits of D-amino acids in this novel medicinal area. 
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1. INTRODUCTION 
Nanomaterials are revolutionizing medicine in the 21
st
 
century by providing novel properties and introducing new 
therapeutic and diagnostic paradigms [1]. The rise of self-
assembling peptide nanostructures [2] and hydrogels has 
brought innovation to various medicinal fields [3], spanning 
from adaptive [4], biodegradable tissue engineering scaffolds 
[5] for wound healing and cell encapsulation, to unprece-
dented paradigms in drug delivery, and even targeted cell 
therapy [6]. Among the many peptide-based systems, low-
molecular-weight gelators deserve special mention as they 
possess an economic advantage over longer peptides or more 
complex peptide-based derivatives [7].  
There are many peptide-based systems that exploit vari-
ous interactions, such as electrostatic interactions, aromatic 
π-π stacking, hydrogen bonding, etc., to drive self-assembly 
and these have been extensively reviewed elsewhere [3]. 
These nanomaterials have well-established advantages as is 
apparent from the majority having been patent-protected and 
some constituting the core technology of spin-off companies 
[8]. 
The incorporation of unnatural D-amino acids in the self-
assembling peptide motifs is an aspect that is attracting more 
and more attention owing to the many, often unexpected, 
effects. From a medicinal perspective, D-amino acids have 
very interesting features. For example, it is well-known that 
incorporation of D-glutamic acid and D-alanine into the bac-
terial cell wall protects it against degradation by exogenous 
proteases [9]. Likewise, albeit less well known, D-serine and 
D-aspartic acid regulate neurotransmission in the brain,  
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where they occur naturally [10]. Insertion of D-amino acids 
into heterochiral peptides is also a convenient approach to 
generate bioactive motifs to promote cell adhesion [11], and 
to control stem cell differentiation [12]. Chirality effects at 
the supramolecular level are far from well understood, and 
those related to interactions with biological entities, or thera-
peutic effects, can be surprising and unanticipated. This as-
pect of biomaterials research is only just emerging but is 
evolving very rapidly.  
In this mini-review we discuss key findings thus far and 
comment on how we view the future directions of such an 
innovative area of research. We discuss only those peptides 
that contain D-amino acids and form macroscopic hydrogels, 
since we are interested in the intentional design and use of 
sequences that self-assemble into hierarchically nanostruc-
tured, macroscopic materials. Sequences that display only 
limited self-assembling ability, leading to isolated nanostruc-
tures, have been excluded.  
In more detail, the focus of this mini-review is the vari-
ous effects and advantages of introducing D-amino acids on 
self-assembling peptides for biomedical use. First, we dis-
cuss enzymatic stability towards, for example, proteases, 
isomerases, racemases, and phosphodiesterases, Second, we 
analyze the effects on peptide conformation, and especially 
on secondary structures that are modified by adding, or even 
intentionally designed to include, D-amino acids at specific 
positions. Third, we highlight the supramolecular behavior 
leading to peptide self-assembly and gelation. Finally, we 
summarize the often unanticipated therapeutic effects that 
follow upon introduction of D-amino acids. 
2. THE ADVANTAGE OF ENZYMATIC STABILITY 
From a medicinal chemist’s perspective, the most obvi-
ous reason to use D-amino acids for biomaterials is their 
theoretically lessened susceptibility to enzymatic processing, 
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and thus their prolonged stability and function in a biological 
environment. We say “theoretical” because although it is 
generally accepted that D-peptides resist the action of prote-
ases relative to their L-analogues, there are surprising exam-
ples of other enzymes that can act upon D-amino acids at the 
same rate as L-amino acids [13].  
Nevertheless, early reports on the use of D-amino acids in 
self-assembled hydrogel biomaterials were conducted under 
the hypothesis of higher stability against enzymatic degrada-
tion. While it may be sufficient to incorporate just a few D-
amino acids [6, 14], the typical approach consists of using 
the full D-enantiomer of an established self-assembling mo-
tif, i.e. substituting all L-amino acids with their D-
counterparts [15]. Increased proteolytic stability is often just 
assumed [16], and only rarely tested, and even with limited 
enzymes such as the most often selected proteinase K [17]. 
Alternatively, chymotrypsin, collagenase, cathepsin B, or 
matrix metalloproteinases (MMP) are useful enzyme models 
[18]. Overall, increased enzymatic stability towards the ac-
tion of peptidases or proteases has been shown in several 
cases, with differences in degradation rates expectedly vary-
ing dependent on sequence and position of the D-amino 
acid(s), as well as conditions applied [19]. From a medicinal 
perspective, inert bulking agents have value, however a 
greater advantage comes when the increased stability is cou-
pled to a therapeutic or diagnostic use, such as the delivery 
of drugs or imaging agents in vivo [15].  
Considering that numerous isomerases, epimerases and 
racemases exist, would it be possible that D-amino acids are 
converted in vivo to their L-enantiomers, which would then 
be susceptible to protease degradation? Such a fate would 
overall reduce the prolonged half-life of peptides bearing D-
amino acids. Actually, all eukaryotic peptide isomerases 
known to date do not process free amino acids, rather, they 
act on single residues of intact peptides and require specific 
flanking sequences for efficient catalysis [20]. Epimerases 
and racemases that act on single amino acids do exist, but 
their presence has been reported mainly in bacteria and some 
plants, effectively making this enzyme class an interesting 
drug target [21]. In addition, their natural substrates are usu-
ally L-amino acids, which are converted to D-, and the oppo-
site reaction may occur but at a much slower rate [22]. Be-
sides, although D-amino acids are increasingly being re-
ported in human aged proteins and often related to aging 
diseases, their occurrence is typically explained by means of 
non-enzymatic racemization [23] with only a very few ex-
ceptions [24]. Therefore, although we cannot exclude the 
possibility of D-amino acid racemization in vivo, this option 
does not appear to be their most likely fate in the human 
body.  
Nevertheless, the assumption that all enzymes, and not 
just proteases, will always process D-amino acids at a slower 
rate than their L-counterparts, if indeed at all, can be at times 
misleading. Care should be taken in this sense, especially in 
light of enzymatic promiscuity. In fact, promiscuous en-
zymes can process unnatural molecules, or molecules other 
than their natural substrates, or even catalyze different or 
opposite reactions than those for which they are designed by 
nature [25]. For instance, it was recently shown that a phos-
phatase dephosphorylates both D- and L-phosphotyrosine-
containing peptides, and at the same rate. This finding can be 
exploited to control the rate of self-assembly, for instance by 
administering a non-assembling phosphate precursor that in 
situ will be enzymatically converted to a gelling peptide 
[13]. There are also other examples of promiscuous enzymes 
that can be exploited to synthesize heterochiral gelling pep-
tides in environmentally-friendly ways, e.g. via lipase-
catalyzed reverse hydrolysis [26]. Interestingly, D-peptide or 
D,L-heterochiral peptide synthesis was achieved with overall 
higher conversion yield, relative to the L-homochiral ana-
logue. This can be explained if we consider that a dynamic 
equilibrium exists, where because of the enzyme’s higher 
affinity for L-peptides, those will be preferentially hydro-
lyzed, and the equilibrium shifted against their production, 
while the opposite holds true for peptides containing D-
amino acids [26]. 
3. EFFECTS ON PEPTIDE CONFORMATION 
3.1. Beta-Turns and Beta-Hairpins 
The use of D-amino acids can be exploited for other rea-
sons, such as their effects on peptide secondary structure 
conformation (Fig. 1). One of the earliest studies seeking 
identification of minimal peptide motifs adopting stable sec-
ondary structures dates back almost 20 years. From a survey 
of the protein database the authors designed a 23-mer capa-
ble of adopting a beta-hairpin conformation (i.e. two beta 
sheets connected by a beta turn, forming a “U” structure, 
Fig. 1A), whose stability was then improved through an it-
erative process [27]. The stabilizing effect of a single D-
proline in a heterochiral type II' turn, as a central structural 
nucleation element, was a crucial finding. Importantly, nei-
ther the hairpin nor the tertiary structure were observed in 
the homochiral control peptide. This study was the first to 
highlight the key structural role played by a single D-amino 
acid, amongst over 20 L-amino acids, in a 23-mer peptide 
secondary conformation. 
Further developments by other authors eventually led to 
the use of a D-proline-based beta-turn in a 20-mer beta-
hairpin motif, able to self-assemble in a macroscopic hydro-
gel [28]. This self-assembling 20-mer is relevant to medici-
nal application. It is compatible with fibroblast cell culture 
conditions and has shown a good performance in terms of 
cytotoxicity in vitro [29]. Interestingly, this amphiphilic pep-
tide, rich in cationic lysine residues, also displays antibacte-
rial properties (see sections below) [30].  
From a medicinal perspective, beta-turn stabilization by 
substitution of L-amino acids with their D-enantiomers is 
now a well-known phenomenon that can be an effective tool 
to increase the binding affinity, and/or biological stability, of 
bioactive peptides [31]. For instance, D-phenylalanine can be 
used to this end to generate a potent, and long-lasting, ana-
logue of α-melanocyte-stimulating hormone [32]. 
3.2. Beta-Sheets 
The introduction of D-amino acids can also have disrup-
tive effects on peptide secondary conformation, depending 
on the amino acid sequence. Introduction of one D-
phenylalanine residue in different positions of naphthalene-
based dipeptide gelators was shown to hamper hydrogela-
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tion. The authors ascribed this fact to reduced intermolecular 
interactions, and thus reduced formation of superstructures, 
possibly due to an altered peptide configuration [19]. In an-
other report, introduction of D-amino acids in different posi-
tions along a self-assembling peptide sequence led to disrup-
tion of the beta-sheet secondary conformation (Fig. 1B) and 
general loss of secondary structure suggesting that, at least 
for that sequence, homochirality is a requirement for peptide 
self-assembly [16].  
Recent studies on unprotected tripeptides bearing the 
Phe-Phe motif and prone to forming beta-sheets revealed an 
opposite trend. In particular, some of us analyzed the su-
pramolecular behavior of the complete Phe-Phe-Val stereoi-
somer series under physiological conditions [33]. This is one 
of the first, and shortest, unprotected peptide sequences iden-
tified as a gelator at neutral pH [34]. Circular dichroism data 
revealed a special role played by the central amino acid on 
the secondary conformation (Fig. 2). Interestingly, this resi-
due alone dictates the chirality of the supramolecular ar-
rangements, even for tripeptides with the other two amino 
acids in opposite stereoconfiguration. However, having a D-
amino acid in this position is not sufficient per se to achieve 
macroscopic hydrogelation for Phe-Phe-Val peptides [33]. 
Self-supportive hydrogels arising from stabilized su-
pramolecular beta-sheet arrangements were observed for the 
Phe-Phe-Val stereoisomers bearing an N-terminal amino acid 
with stereoconfiguration different from the other two amino 
acids (i.e. 
D
Phe-
L
Phe-
L
Val and its enantiomer 
L
Phe-
D
Phe-
D
Val). Limited beta-sheet nanostructures were observed by 
microscopy in the case of other heterochiral, but not homo-
chiral, peptides, and importantly, both hydrogels with either 
L- or D-supramolecular chirality supported fibroblast cell 
culture and did not result in cell cytotoxicity in solution [33].  
These are not the only reports of D-amino acids promot-
ing beta-sheet formation. For instance, one study analyzed a 
series of peptides made of two γ -amino acids at the N-
terminal, followed by the D-pentamer 
D
Lys-
D
Leu-
D
Val-
D
Phe-
D
Phe. Considering that γ -peptides are prone to helix forma-
tion, the D-pentamer, which is prone to beta–sheet formation, 
had a predominant effect on the overall peptide secondary 
conformation. In one example, the beta-sheet structure was 
observed in dilute solutions of concentrations at which other 
peptides do not fold, suggesting a stabilizing effect played by 
the amino acid sequence bearing the D-residues [35]. 
Finally, in one case an interesting temperature-dependent 
secondary conformation was observed only for a D-
enantiomer and not for its L-counterpart. The secondary con-
formation stability was tested by circular dichroism under 
various conditions of pH, ionic strength, temperature, and 
denaturing agents (i.e. urea or SDS). The two enantiomers 
displayed identical behavior under all conditions except for 
the thermal treatment. In particular, the L-enantiomer main-
tained a highly stable beta-sheet conformation at tempera-
tures as high as 110 °C, while its D-enantiomer underwent a 
reversible transition towards alpha-helix with heating, sug-
gesting a lower thermal stability of the supramolecular D-
amino acid arrangements [15]. 
3.3. Alpha-Helices 
In contrast to beta-sheet forming peptides, we could lo-
cate only one report on heterochiral self-assembled gels 
based on alpha helices (Fig. 1C). Insertion of even a single 
D-amino acid in a 14-mer amphipathic peptide completely 
abolished hydrogel formation, suggesting that alpha-helices 
were better preserved in homochiral, rather than heterochiral, 
peptide sequences [36]. 
4. EFFECTS ON SELF-ASSEMBLY AND GELATION 
It is difficult to predict the self-assembly behavior of het-
erochiral peptides and peptide derivatives, and it has been 
shown that even the insertion of a single D-amino acid in a 
peptide sequence can significantly alter the peptide su-
pramolecular behavior, and in different ways, depending on 
the sequence and the D-amino acid position. 
Some of us were the first to report on the use of amino 
acid chirality as a tool to induce gelation of unprotected 
tripeptides, the shortest peptide motifs that gel in in vitro 
physiological conditions, without the use of organic solvents 
[34]. In particular, we observed that, under conditions at 
which the homochiral sequences Val-Phe-Phe, Phe-Phe-Val, 
or Leu-Phe-Phe do not gel, their heterochiral analogues bear-
ing a D-amino acid at the N-terminal rapidly form self-
supportive hydrogels based on antiparallel beta-sheets [34, 
37]. Interestingly, despite the very subtle differences in 
amino acid sequence, the three heterochiral peptides 
D
Val-
Phe-Phe, 
D
Phe-Phe-Val, and 
D
Leu-Phe-Phe form different 
nanostructures, i.e., nanotapes, twisted fibers, and thick bun-
dles, respectively [34, 37]. Molecular modelling and XRD 
studies point to a supramolecular stabilizing effect played by 
heterochirality. By contrast with the homochiral stereoi-
somers, presence of both D- and L- amino acids removes key 
steric clashes between side chains, and allows for the forma-
tion of peptide stacks that interdigitate via phenylalanine 
zippers into superstructures with hierarchical order [37]. As a 
result, gelation occurs as rapidly as within seconds, as shown 
in a video [37]. 
Fig. (1). Examples of peptide secondary conformation. Adapted from ref. [3] with kind permission from The Royal Society of Chemistry. 
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Another interesting study analyzed the supramolecular 
behavior of low-molecular-weight gelators based on dipep-
tide amphiphiles (Fig. 3). This work showed that the chiral-
ity of the C-terminal amino acid dictates the chiral orienta-
tion of the supramolecular helical nanoribbons, with on one 
hand the 
L
Ala-
D
Ala derivative having the same handedness 
as the 
D
Ala-
D
Ala counterpart, and on the other hand the 
D
Ala-
L
Ala derivative having the same handedness as the 
L
Ala-
L
Ala analogue [38]. 
In addition, homochiral and heterochiral effects have 
been analyzed for the case of multi-component self-
assembled hydrogels, where homochirality of the peptide 
building blocks appeared to confer mechanical advantages 
relative to mixtures of both L- and D-peptides [39]. Contrar-
ily, the opposite trend has been reported for racemic mix-
tures assembling into nanostructured gels. In one example of 
a beta-hairpin peptide an equimolar mixture of the two enan-
tiomers displayed enhanced mechanical rigidity, with an 
elastic modulus G’ that was four times higher than that of 
each peptide gel, under identical conditions. Microscopy 
images revealed an unaltered nanofibril morphology and the 
authors proposed that enantiomers may interact either at the 
molecular, or at the supramolecular, level forming mixed 
fibrils or self-segregating into separate fibrils, respectively 
(Fig. 4) [40].  
Follow-up work by other authors on amphipathic pep-
tides showed that enantiomers do not self-sort, rather they 
form hybrid beta-sheets with alternating L- and D-peptides, 
as confirmed by FRET analysis. The elegant study labelled 
the peptides with a fluorophore/quencher Förster pair with a 
radius of 3.3 nm. Fluorescence endured upon mixing of pre-
formed fibrils of each peptide enantiomer, while pre-mixing 
of an equimolar racemic mixture displayed complete fluores-
cence quenching, indicating that the two enantiomers were 
homogeneously distributed within a distance of 3.3 nm be-
tween each other, as would occur in alternating positions 
within beta-sheets [41].  
Interestingly, an earlier study on enantiomers of poly-
lysine reported that the equimolar racemate formed self-
assembled amyloid-like nanofibrillar structures arising from 
beta-sheets at room temperature, while each enantiomer sin-
gly required higher temperatures to undergo an alpha helix-
to beta-sheet transition. The authors postulated a stabilized 
supramolecular structure in the former [42].  
 
Fig. (2). Circular dichroism (CD) spectra of heterochiral Phe-Phe-Val tripeptides reveal that chirality of supramolecular arrangements is 
dictated by the stereoconfiguration of the central amino acid. A) 
L
Phe-
L
Phe-
L
Val (black line) and 
D
Phe-
D
Phe-
D
Val (dotted line) enantiomers; 
(B) 
D
Phe-
L
Phe-
L
Val (black line) and 
L
Phe-
D
Phe-
D
Val (dotted line) enantiomers; (C) 
D
Phe-
L
Phe-
D
Val (black line) and 
L
Phe-
D
Phe-
L
Val (dotted 
line) enantiomers; (D) 
L
Phe-
L
Phe-
D
Val (black line) and 
D
Phe-
D
Phe-
L
Val (dotted line) enantiomers. Reprinted from ref. [33] with kind permis-
sion of The Royal Society of Chemistry. 
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Overall, all these studies are in agreement with a stabi-
lized supramolecular amyloid-like beta-sheet nanostructure 
arising from the equimolar mixture of two peptide enanti-
omers, relative to each peptide alone. This is an intriguing 
finding that deserves further investigation as it may have 
important implications for the design of future lead candi-
dates to treat amyloidosis. 
5. THERAPEUTIC EFFECTS 
5.1. Antimicrobial Activity 
Heterochiral gelling peptides have also shown interesting 
antibacterial properties. In particular, a 20-mer beta-hairpin 
peptide hydrogel displayed antibacterial activity exerted 
through membrane disruption [30]. In light of its polyca-
tionic nature it is possible that its mechanism of action is 
analogous to the one of antimicrobial peptides carrying posi-
tive charges [43]. In this regard it is interesting to note that 
the introduction of D-amino acids can also enhance the activ-
ity and selectivity of antimicrobial peptides [44]. When the 
side chains are not ionizable the situation is different. For 
instance, some of us reported on the use of the heterochiral 
gelling 
D
Leu-
L
Phe-
L
Phe tripeptide as biomaterial, which sur-
prisingly displayed a mild antibacterial activity against the 
Gram-negative strains E.coli and a clinical strain of 
K.pneumoniae (Fig. 5) [45]. Interestingly, such an activity 
was observed neither in the self-assembling gelling analogue 
D
Val-
L
Phe-
L
Phe, which differs by only a methylene unit, nor 
in the case of the scrambled sequence 
L
Phe-
D
Leu-
L
Phe or of 
single amino acids 
D
Leu and 
L
Phe. This observation suggests 
the effect is sequence-dependent and not simply due to the 
 
Fig. (3). Ala-Ala dipeptide amphiphiles form helical nanoribbons with a handedness dictated by chirality of the C-terminal amino acid, as 
observed by AFM. A. left-handed nanoribbons. B. right-handed nanoribbons. Adapted with permission from ref. [38]. Copyright © 2013 
American Chemical Society.  
 
Fig. (4). An equimolar mixture of two self-assembling peptide enantiomers can give rise to A. mixed fibrils, each containing both peptides, 
or B. self-sorted fibrils, each containing one peptide only. Adapted with permission from ref. [40]. Copyright © 2011 American Chemical 
Society. 
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supramolecular arrangement, giving scope for the develop-
ment of novel antimicrobial peptides. Importantly, no hemo-
lytic side effect was observed despite this being an often 
observed adverse phenomenon for antimicrobial peptides. 
Nevertheless, further studies are needed to elucidate the ex-
act mechanism of action and further investigate the possibil-
ity to optimize the antibacterial activity. 
5.2. Amyloidosis Therapy 
The rationale to use self-assembling peptides bearing D-
amino acids to treat amyloidosis comes from the fact that 
many self-assembling peptide sequences are indeed inspired 
from the core residues found in various amyloids, with Alz-
heimer’s Aβ(1-42) peptide being the most studied [46]. Spe-
cifically, a number of variations around the Lys-Leu-Val-
Phe-Phe pentamer of Aβ have been designed to achieve soft 
materials, and even the pentamer itself displayed the ability 
to form hydrogels [47]. In light of the tendency of the pep-
tide to bind to itself, thus forming the so-called amyloid ag-
gregates, it can be envisaged that small peptides of similar 
amino acid sequence may compete with such binding, thus 
interfering with amyloid formation. As far as D-amino acids 
are concerned, it is worth noting that N-terminal conjugation 
of 
D
Lys-
D
Leu-
D
Val-
D
Phe-
D
Phe with a γ-dipeptide generated a 
promising lead compound to treat amyloidosis (Fig. 6). The 
resulting heptamer was capable of binding to the Aβ(1-42) 
peptide, thus reducing its cytotoxicity with a favourable 
dose-response curve at physiologically relevant concentra-
tion conditions [35]. 
5.3. Enhancement of Drug Selectivity 
The covalent appendage of a peptide gelator to a drug 
can offer interesting means to fine-tune drug activity and 
selectivity. For instance, the anti-inflammatory drug 
naproxen displays a convenient carboxylic acid group that 
can be used to couple a peptide via either a terminal amine or 
via the amino side chain of a lysine residue [48]. Molecular 
modelling studies of the COX-2 target enzyme showed that 
the active site could accommodate a rather bulky 
D
Phe-
D
Phe 
dipeptide without compromising drug activity. In fact, ex-
perimental IC50s of drug conjugates with short, gelling, D-
peptides showed increased values relative to the drug alone. 
However, in the case of 
D
Phe-
D
Phe-
D
Lys-
D
Tyr the increase 
was only minor and did not inhibit drug activity. Impor-
tantly, COX-2 selectivity over COX-1 appeared improved 
for the drug-peptide conjugates relative to the drug alone, 
and the effect was not observed in the case of the L-peptide 
enantiomers. In principle this approach offers an elegant 
method to enhance drug selectivity and reduce COX-1 de-
pendent side effects [48]. 
5.4. Hemostasis 
Gel formation has also been envisaged as a means to cre-
ate an artificial blood clot to treat hemorrhages in fibrinogen-
deficient patients. The authors designed a compound featur-
ing a PEG-D-peptide conjugate to assist with solubility, fol-
lowed by a thrombin-recognition motif, and a D-peptide ge-
lator (Fig 7). Despite the complexity of human plasma com-
position, addition of the compound and thromboplastin to 
fibrinogen-depleted human plasma led to a cascade of 
events, namely: 1) thrombin activation by thromboplastin, 2) 
compound enzymatic cleavage by activated thrombin, and 3) 
gelation, effectively forming an artificial blood clot. The 
authors envisaged use of the system in bandages to treat se-
vere wounds and traumas [42].  
Another study exploited gelation of an amphipathic D-
peptide to stop in vivo bleeding arising from a liver wound in 
a rabbit model. The peptide and its enantiomer, thanks to 
their self-assembling ability, were able to lead to hemostasis 
within 20 seconds. In contrast, the D,L-heterochiral ana-
logues, which presented minor self-assembling ability, took 
significantly longer to have the same effect [13]. The process 
exploited the gelation-promoting role played by the abundant 
salts naturally present in blood to accelerate self-assembly. 
N
H
H2N
O
O
H
N
N
H
H
N
O
O
O
N
H
O
H
N
O
OH
NH2  
Fig. (6). Promising lead candidate to inhibit Aβ peptide aggregation 
[35]. 
 
Fig. (5). Antibacterial activity of self-assembling 
D
Leu-
L
Phe-
L
Phe peptide gel alone (i.e., control, top half of agar plates) or co-assembled 
with antibiotic ciprofloxacin (i.e., CIP, bottom half of agar plates). Reprinted from ref. [45] Copyright © 2013 with permission from El-
sevier. 
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Fig. (7). Heterochiral peptide derivative with a thrombin cleavage 
site (indicated by the scissors) to release a self-assembling gelator 
[42]. 
6. DRUG DELIVERY APPLICATIONS 
Hydrogels are widely used as vehicles for drug delivery, 
and so it is not surprising that systems of gelling peptides 
bearing D-amino acid(s) were designed for this purpose. 
Drug loading and delivery can be achieved in different ways. 
From a purely chemical point of view we can envisage the 
drug being bound either non-covalently or covalently to the 
gel matrix, and examples of both will be briefly discussed 
below. 
The most obvious non-covalent approach consists of 
simple drug encapsulation into the hydrogel matrix. For in-
stance, curcumin could be used as a model compound for 
hydrophobic drugs. The drug could be dissolved with vari-
ous amounts of the peptide gelator in order to fine-tune the 
gel’s viscoelastic properties, and thus the drug release rate 
[49]. It is worth noting that this is simply a physical process, 
since the circular dichroism spectroscopic profile of the gel 
was not altered by the presence of the drug, suggesting that 
the peptide assembled in the same manner either with or 
without curcumin [49]. A similar approach can be applied 
also to other hydrophobic drugs. 10-hydroxycamptothecin 
was encapsulated into D-amino acid bearing self-assembling 
peptides without altering the fiber nanomorphology. It is 
worth noting that the heterochiral peptide was able to in-
crease the aqueous stability of the drug to a higher extent 
than the L-homochiral peptide counterpart, suggesting a po-
tential use as stabilizer in drug formulations [6]. 
A more interesting option offered by supramolecular gels 
is the possibility of the drug to participate in the assembly 
process, i.e. being integrated in the gel matrix architecture. 
For instance, a poorly soluble hydrophobic drug can interact 
with the hydrophobic heterochiral tripeptide 
D
Leu-Phe-Phe 
via π-π stacking, as shown by circular dichroism (CD) spec-
troscopy [45]. Co-assembly clearly affected the su-
pramolecular architecture, yielding different nanomorphol-
ogy and different rheological properties of the resulting soft 
material. Importantly, thanks to the competition between 
drug-peptide and drug-drug interactions, precipitation did 
not occur and the drug could be loaded in the hydrogel at 
physiological conditions, and at concentrations superior to its 
solubility limit [45]. Clearly this approach offers an interest-
ing alternative for the delivery of poorly-soluble drugs. 
Alternatively, gelling peptides and drugs can be cova-
lently linked to each other. As an example, the carboxylic 
end of the anti-inflammatory drug naproxen was bound to 
the D-peptides 
D
Phe-
D
Phe-
D
Lys, 
D
Phe-
D
Phe-
D
Tyr, and 
D
Phe-
D
Phe-
D
Lys-
D
Tyr. Hydrogels were obtained at neutral pH, 
either by using a combined temperature and pH trigger, or by 
using phosphotyrosine-bearing non-gelling precursors that 
were dephosphorylated in situ upon action of a phosphatase 
[48]. The covalent conjugation of the drug with a D-peptide 
to obtain a hydrogel for medicinal use is not a trivial matter 
and can have dramatic effects on the gelation properties. 
Indeed, conjugation of the short sequence 
D
Phe-
D
Phe ham-
pered the gelation process at neutral pH, and formed a com-
pound that gelled only at a pH as acidic as 4 [48].  
Finally, one study showed that peptides containing D-
amino acids, when self-assembled, enriched at the cell mem-
brane, but not when concentrations were too low for the su-
pramolecular structures to arise. This observation could in 
principle be exploited for the targeted delivery of a small 
molecule that has a specific site of action located at the cell 
membrane [50]. 
7. BIOMATERIALS USE AND CYTOTOXICITY 
Self-assembled peptides are popular building blocks for 
soft biomaterials thanks to their well-established chemistry, 
natural occurrence, possibility to encode a biological mes-
sage, and biodegradability [51]. Besides, nanostructured pep-
tide hydrogels offer an ideal environment for tissue regenera-
tion and wound healing, by providing a good mimic of the 
physicochemical properties of the extracellular matrix as 
well as maintaining an appropriate level of moisture to favor 
cellular metabolic exchanges and movement [5]. 
However, in the case of heterochiral peptides or D-
peptides not much is known about their biocompatibility, 
and in fact only a few reports have addressed the issue thus 
far. One may presume that in light of their lower enzyme 
sensitivity relative to L-peptides, D-peptides may lead to 
more adverse effects in vitro, and perhaps more so in vivo. 
Indeed, there is one report of a L-peptide gel leading to 
milder inflammation response relative to the D-enantiomer in 
vivo, with a thicker collagen capsule being formed around 
the latter [18]. Nevertheless, cytotoxicity has to be ascer-
tained case by case.  
In terms of comparisons between enantiomers, obviously 
biological effects will be sequence-dependent, just as in the 
case of chiral small molecules, where stereochemistry-
dependent biological effects of each enantiomer are strongly 
dependent on the small molecule chemical identity. In the 
case of homochiral peptides, at times it is the D-peptide de-
rivative that is less cytotoxic in cell culture in vitro than its 
L-analogue [52]. On the other hand, other examples were 
reported of the L-enantiomer in vitro having lower cytotoxic-
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ity than either its D-counterpart or the racemic mixture [53]. 
Finally, there are also cases of identical performance for ei-
ther enantiomer used as 3D-scaffold for cell-culture cytotox-
icity assays in vitro [54].  
Similarly, and also in the case of heterochiral peptide 
gels, it is difficult to anticipate which enantiomer will per-
form better form a biological viewpoint. As mentioned in the 
sections above, some of us identified the first uncapped 
tripeptides capable of gelation at physiological conditions, 
without the aid of organic solvents, and indeed these com-
pounds were envisaged for their use as nanostructured bio-
materials [55]. These hydrophobic, heterochiral peptides 
performed well in fibroblast cell culture, even in the case of 
supramolecular structures with unnatural D-chirality (Fig. 8). 
Interestingly, cell penetration within the gel, and instances of 
cell spreading, were observed despite the absence of bioac-
tive motifs promoting cell adhesion. No obvious difference 
between the biological effects induced by each heterochiral 
enantiomer was noted [33]. This data suggested an overall 
benign interaction with cells, as supported by cytotoxicity 
assays on the peptides in solution [33], and by hemolytic 
assays [45]. Also other authors reported lack of cytotoxicity 
for heterochiral self-assembling peptides. Use of self-
assembling heterochiral peptides bearing the tumor targeting 
RGD-sequence, a motif binding to integrin proteins [56], led 
to good tumor selectivity both in vivo and in vitro, with 
lower toxicity observed for non-cancerous cells [6].  
CONCLUSION 
Introduction of D-amino acids to self-assembling peptide 
gels started quite a few years ago with the simple aim to 
achieve higher stability against enzymatic degradation, and 
to thus enhance their durability as biomaterials. However, as 
more and more investigators adopted the use of D-amino 
acids in hydrogel biomaterials, unexpected effects on peptide 
secondary conformation, self-assembly behavior, and even 
biological performance were observed. Overall, this growing 
body of work is showing that peptide chirality has a lot more 
to offer than simply enzyme stability, and often hints at 
benefits that might be exploited by the medicinal chemist. 
Enhancements in drug delivery, selectivity, and potency 
have been achieved through the use of peptides displaying D-
amino acid(s) in their sequence. Novel paradigms of therapy 
and cell compartment targeting are being envisaged too. We 
believe that peptide chirality is indeed a versatile tool for the 
medicinal chemist, and creativity is the only limit for its 
wider application to find novel solutions in therapy for the 
21
st
 century. 
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Fig. (8). Heterochiral self-assembling peptides 
D
Phe-
L
Phe-
L
Val (i.e., fFV) and 
L
Phe-
D
Phe-
D
Val (i.e., Ffv) perform equally well in cytotoxic-
ity tests both in solution (left) and as gels (right). Circles indicate spreading cells. Scale bar = 50 µm. Adapted from ref. [33] with kind 
permission of The Royal Society of Chemistry. 
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